PhillyCooke Consulting
21st Century FDA Ad-Promo Expertise
(Move to ...)
Overview
Regulatory Rx Blog
Agency Support
Consulting & Training
About PhillyCooke
Contact PhillyCooke
▼
Recap of FDLI #AdPromo2023
›
Disclosure: I sit on the Planning Committee for the FDLI Ad-Promo conference. This is an unpaid, volunteer position. The contents of this po...
New On-Demand Training Platform
›
I am pleased to announce the availability of on-demand training about FDA's regulation of advertising and promotion. So, you are now abl...
COVID-19 & Ad-Promo
›
The COVID-19 pandemic has brought to the fore some issues of ad-promo for FDA-regulated products. I'm posting here to highlight some dev...
COVID-19 Outbreak Pausing Live Speaking Engagements
›
I live in Pennsylvania, just outside Philadelphia, in Montgomery County. Currently, Montco is the worst hit county in Pennsylvania for the C...
2020 CDER Guidance Agenda Released
›
UPDATE: The guidance mentioned below was released. Here's the link. The FDA has released the CDER Guidance Agenda . For ad-promo profe...
Temple RA/QA Advertising Course
›
It was just confirmed that I'll be teaching in Temple University's RA/QA MS program this spring. Specifically, I'll be teaching ...
DHC Privacy Post
›
The Digital Health Coalition asked for my views on the renewed emphasis on privacy for pharmaceutical marketers. I shared a few thoughts here .
›
Home
View web version